NL170229C - Farmaceutisch combinatiepreparaat. - Google Patents

Farmaceutisch combinatiepreparaat.

Info

Publication number
NL170229C
NL170229C NLAANVRAGE7211501,A NL7211501A NL170229C NL 170229 C NL170229 C NL 170229C NL 7211501 A NL7211501 A NL 7211501A NL 170229 C NL170229 C NL 170229C
Authority
NL
Netherlands
Prior art keywords
pharmaceutical combination
combination preparation
preparation
pharmaceutical
combination
Prior art date
Application number
NLAANVRAGE7211501,A
Other languages
English (en)
Dutch (nl)
Other versions
NL7211501A (xx
NL170229B (nl
Original Assignee
Syntex Pharma Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Pharma Int filed Critical Syntex Pharma Int
Publication of NL7211501A publication Critical patent/NL7211501A/xx
Publication of NL170229B publication Critical patent/NL170229B/xx
Application granted granted Critical
Publication of NL170229C publication Critical patent/NL170229C/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NLAANVRAGE7211501,A 1971-08-25 1972-08-23 Farmaceutisch combinatiepreparaat. NL170229C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17493471A 1971-08-25 1971-08-25

Publications (3)

Publication Number Publication Date
NL7211501A NL7211501A (xx) 1973-02-27
NL170229B NL170229B (nl) 1982-05-17
NL170229C true NL170229C (nl) 1982-10-18

Family

ID=22638126

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7211501,A NL170229C (nl) 1971-08-25 1972-08-23 Farmaceutisch combinatiepreparaat.

Country Status (6)

Country Link
US (1) US3733407A (xx)
BE (1) BE788010A (xx)
DE (1) DE2241740A1 (xx)
FR (1) FR2150850B1 (xx)
GB (1) GB1397441A (xx)
NL (1) NL170229C (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2310963A1 (de) * 1972-04-14 1974-09-05 Schering Ag Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten
US4066757A (en) * 1973-03-26 1978-01-03 Ortho Pharmaceutical Corporation Oral contraceptive regimen
DE2365103C3 (de) * 1973-12-21 1980-08-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen V erwendung von Hormonen zur Kontrazeption
US4315925A (en) * 1980-05-30 1982-02-16 University Of Kentucky Research Foundation Method of administering natural female sex hormones
US4425339A (en) * 1981-04-09 1984-01-10 Syntex (U.S.A.) Inc. Treatment of menopausal symptoms
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4961931A (en) * 1982-07-29 1990-10-09 Alza Corporation Method for the management of hyperplasia
AU582540B2 (en) * 1983-08-05 1989-04-06 Pre Jay Holdings Ltd. A method of hormonal treatment of perimenopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
US5188835A (en) * 1986-06-16 1993-02-23 Kabi Pharmacia Ab Intravaginal devices
US4900734A (en) * 1987-08-27 1990-02-13 Maxson Wayne S Novel pharmaceutical composition containing estradiol and progesterone for oral administration
DE4104385C1 (xx) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich
DE4313926A1 (de) * 1993-04-28 1994-11-03 Jenapharm Gmbh Pharmazeutisches Mehrphasenpräparat zur hormonalen Kontrazeption
DE4342091A1 (de) * 1993-12-09 1995-06-14 Asta Medica Ag Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten
DE4344405C2 (de) * 1993-12-24 1995-12-07 Marika Dr Med Ehrlich Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption
US5789443A (en) * 1997-04-25 1998-08-04 Gollobin; Charlotte Method for treating flushing associated with menopause
US6703367B1 (en) 1999-04-27 2004-03-09 Praecis Pharmaceuticals Inc. Methods for treating hot flashes and gynaecomastia
US6245812B1 (en) 1999-07-15 2001-06-12 Charlotte Gollobin Treatment of hot flashes (flushing) using leucine alone or in combination with other branched chain amino acids
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US6660726B2 (en) * 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
WO2004091535A2 (en) * 2003-04-11 2004-10-28 Barr Laboratories, Inc. Methods of administering estrogens and progestins
US7623924B2 (en) * 2004-08-31 2009-11-24 Leptos Biomedical, Inc. Devices and methods for gynecologic hormone modulation in mammals
EP1853272A1 (en) * 2005-02-03 2007-11-14 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
UY33103A (es) 2009-12-15 2011-07-29 Techsphere S A De C V Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico
CN117883212B (zh) * 2024-03-15 2024-07-09 中国中医科学院中药研究所 一种改良型经前期综合征动物模型的构建方法和动物模型及应用

Also Published As

Publication number Publication date
GB1397441A (en) 1975-06-11
FR2150850B1 (xx) 1977-08-05
NL7211501A (xx) 1973-02-27
NL170229B (nl) 1982-05-17
FR2150850A1 (xx) 1973-04-13
US3733407A (en) 1973-05-15
BE788010A (fr) 1972-12-18
DE2241740A1 (de) 1973-03-01

Similar Documents

Publication Publication Date Title
NL170229C (nl) Farmaceutisch combinatiepreparaat.
NL7404907A (nl) Huid-preparaat.
CH558663A (de) Ballschlaeger.
BE783967A (nl) Galvaniseerinrichting.
NL167598C (nl) Injectiespuit.
CH555461A (de) Echafaudage.
CH554480A (de) Harmonikatuere.
CH547567A (de) Turbogenerater.
CH553706A (de) Foerderer.
NL169957C (nl) Injectiespuit.
NO137260C (no) Antitranspirasjonspreparat.
BE772520A (fr) Stroomonderbrekingselement.
CH556032A (de) Retroreflecteur.
CH558421A (de) Allume-feu.
CH547101A (de) Trocart.
CH555181A (de) Schampooing.
CH547215A (fr) Aerosol-ventil.
DK130556B (da) Vaterpas.
BE770100A (fr) Meerpas draadtrekmachine.
CH546033A (de) Melkbecher.
NO137259C (no) Antitranspirasjonspreparat.
CH557650A (de) Surchaussure aseptique.
BE766327A (fr) Roeimecanisme.
BE772416A (fr) Brilmontuur.
BE772932A (fr) Zitmeubel.

Legal Events

Date Code Title Description
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: SYNTEX PHARMACEUTICALS INTERNATIONAL LIMITED

V2 Lapsed due to non-payment of the last due maintenance fee for the patent application